Bismuth oxide salicylate

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Remarks:

Type of genotoxicity: gene mutation

Type of information:

experimental study

Adequacy of study:

key study

Study period:

no data available

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Well documented publication.

Data source

Reference

Reference Type:

publication

Title:

Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals.

Author:

Zeiger, E.; et al.

Year:

1986

Bibliographic source:

Environ. Mutagen. 9, 1-109

Materials and methods

Test guideline

Qualifier:

equivalent or similar to guideline

Guideline:

OECD Guideline 471 (Bacterial Reverse Mutation Assay)

Deviations:

not specified

GLP compliance:

no

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

Bismuth oxide salicylate

EC Number:

238-953-1

EC Name:

Bismuth oxide salicylate

Cas Number:

14882-18-9

Molecular formula:

C7H5BiO4

IUPAC Name:

2-hydroxy-4H-1,3,2-benzodioxabismin-4-one

Details on test material:

- Name of test material (as cited in study report): Bismuth subsalicylate
- No further details are given.

Method

Species / strain

Species / strain / cell type:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Metabolic activation:

with and without

Metabolic activation system:

S9-mix

Test concentrations with justification for top dose:

The test substance was tested initially at half-log doses up to a dose that elicited toxicity.
Doses: 0, 3.3, 10, 33, 100, 333, 666 µg/plate

Vehicle / solvent:

- Vehicle(s)/solvent(s) used: DMSO
A maximum of 0.05 mL solvent was added to each plate.

Controls

Controls 1

Untreated negative controls:

no

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

sodium azide

Remarks:

without metabolic activation; strains TA1535 and TA100

Controls 2

Untreated negative controls:

no

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

9-aminoacridine

Remarks:

without metabolic activation; strains TA97 and TA1537)

Controls 3

Untreated negative controls:

no

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

other: 4-nitro-o-phenylendiamine

Remarks:

without metabolic activation; strain TA98

Controls 4

Untreated negative controls:

no

Negative solvent / vehicle controls:

yes

True negative controls:

no

Positive controls:

yes

Positive control substance:

other: 2-aminoanthracene

Remarks:

with metabolic activation; all strains

Details on test system and experimental conditions:

METHOD OF APPLICATION: preincubation

DURATION
- Preincubation period: 20 minutes at 37°C
- Expression time: The histidine-revertant (his+) colonies arising on these plates were counted following 2 days incubation at 37°C.

NUMBER OF REPLICATIONS: At least 5 doses were tested in triplicate. Experiments were repeated at least 1 week following the initial trial.

EVALUATION: The plates were hand-counted when a precipitate was present; otherwise automatic colony counters were used.

DETERMINATION OF CYTOTOXICITY
- Method: The test substance was tested initially in a toxicity assay to determine the appropriate dose range. The toxicity assay was performed by using TA 100. Toxic concentrations were those at which a decrease in the number of his+ colonies was seen or at which there was a clearing in the density of the background lawn.

No further details are given.

Evaluation criteria:

An individual trial was judged mutagenic (+) if a dose-related increase over the corresponding solvent control was seen, and it was judged weekly mutagenic (+W) if a low-level dose response was seen. A trial was considered questionable if a dose-related increase was judged insufficiently high to justify a call of "+W", if only a single dose was elevated over the control, or if a non-dose-related increase was seen.
A chemical was judged to be mutagenic, or weakly mutagenic, if it produced a reproducible, dose-related increase in his+ revertants over the corresponding solvent controls in replicate trials. A chemical was considered to be questionable if a reproducible increase of his+ revertants did not meet the criteria for either a mutagenic or weakly mutagenic, or if only single doses produced an increase in his+ revertants in repeat trials.

Statistics:

According to the guideline for a bacterial reverse mutation assay (e.g. Ames test), statistical analysis is not mandatory.

Results and discussion

Test results

Species / strain:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

not specified

Vehicle controls validity:

valid

Untreated negative controls validity:

not examined

Positive controls validity:

valid

Additional information on results:

No further details are reported.

Remarks on result:

other: all strains/cell types tested

Remarks:

Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information):
negative

Bismuth subsalicylate is non mutagenic in the reverse mutation assay with Salmonella typhimurium, tested with doses up to 666µg/plate.

Executive summary:

Bismuth subsalicylate is non mutagenic in the reverse mutation assay with Salmonella typhimurium, tested with doses up to 666µg/plate.